Wood River Health Services, Inc.: drugs

Schedule G of this filing lists 56 drugs, with an amount and a number of claims for each, as filed. Every amount links to its page of the filing.

The schedule's total is printed as “Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement”. The filings describe the amounts in more than one way. Methods says more.

All 56 drug rows

Schedule G as filed, for Wood River Health Services, Inc.: 56 drugs, in the order filed
LineDrugAmount as filedClaims as filed
1Zavzpret spr 10 mg00069350002Listed by the FDA as Zavzpretzavegepant10 mg/0.1 mLsprayPfizer Laboratories Div Pfizer Inc5,355 (Schedule G, line 1, page 8 of the filing PDF)8
2Brixadi SY356 mg/mL0.27MLER SPD C358284029601Listed by the FDA as Brixadibuprenorphine96 mg/0.27 mLinjectionBraeburn Inc.5,934 (Schedule G, line 2, page 8 of the filing PDF)fewer than 6 (the count is not shown)
3Trulicity inj 1.5/0.500002143480Listed by the FDA as Trulicitydulaglutide1.5 mg/0.5 mLinjection, solutionEli Lilly and Company6,062 (Schedule G, line 3, page 8 of the filing PDF)14
4Fycompa tab 8 mg69616027830Listed by the FDA as Fycompaperampanel8 mgtabletCatalyst Pharmaceuticals, Inc.6,066 (Schedule G, line 4, page 8 of the filing PDF)12
5Wixela Inhub aer 500/5000378932232Listed by the FDA as Wixela Inhubfluticasone propionate and salmeterol500 mcg; 50 mcgpowderMylan Pharmaceuticals Inc.6,099 (Schedule G, line 5, page 8 of the filing PDF)73
6Valtoco spr 15 mg72252051510Listed by the FDA as Valtocodiazepam7.5 mg/0.1 mLsprayNeurelis, Inc6,237 (Schedule G, line 6, page 8 of the filing PDF)7
9Paxlovid tab 150-10000069531720Listed by the FDA as Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc6,480 (Schedule G, line 9, page 8 of the filing PDF)6
10Paxlovid tab 300-10000069504530Listed by the FDA as Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc6,542 (Schedule G, line 10, page 8 of the filing PDF)8
11Basaglar inj 100 units00002771559Listed by the FDA as Basaglar KwikPeninsulin glargine100 IU/mLinjection, solutionEli Lilly and Company6,763 (Schedule G, line 11, page 8 of the filing PDF)14
12Vraylar cap 1.5 mg61874011530Listed by the FDA as Vraylarcariprazine1.5 mgcapsule, gelatin coatedAllergan, Inc.6,773 (Schedule G, line 12, page 8 of the filing PDF)8
13Wegovy pen 0.5 mg/0.5 mL NOV400169450514Listed by the FDA as Wegovysemaglutide0.5 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP6,938 (Schedule G, line 13, page 8 of the filing PDF)14
14Descovy61958200201Listed by the FDA as Descovyemtricitabine and tenofovir alafenamide200 mg; 25 mgtabletGilead Sciences, Inc.7,470 (Schedule G, line 14, page 8 of the filing PDF)fewer than 6 (the count is not shown)
15Wixela Inhub aer 250/5000378932132Listed by the FDA as Wixela Inhubfluticasone propionate and salmeterol250 mcg; 50 mcgpowderMylan Pharmaceuticals Inc.9,251 (Schedule G, line 15, page 8 of the filing PDF)164
16Zepbound inj 5/0.5 mL00002249580Listed by the FDA as Zepboundtirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company9,906 (Schedule G, line 16, page 8 of the filing PDF)12
17Sublocade inj 100 mg/0.5 mL 112496010001Listed by the FDA as Sublocadebuprenorphine100 mgsolutionIndivior Inc.11,143 (Schedule G, line 17, page 8 of the filing PDF)8
18Humira CF auto inj 40 mg/0.4 mL 200074055402Listed by the FDA as HumiraadalimumabkitAbbVie Inc.11,209 (Schedule G, line 18, page 8 of the filing PDF)8
19Ajovy inj 225/1.551759020210Listed by the FDA as Ajovyfremanezumab-vfrm225 mg/1.5 mLinjectionTeva Pharmaceuticals USA, Inc.11,582 (Schedule G, line 19, page 8 of the filing PDF)78
20Rexulti tab 0.5 mg59148003613Listed by the FDA as Rexultibrexpiprazole0.5 mgtabletOtsuka America Pharmaceutical, Inc.11,639 (Schedule G, line 20, page 8 of the filing PDF)15
21Zepbound inj 7.5/0.500002248480Listed by the FDA as Zepboundtirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company11,659 (Schedule G, line 21, page 9 of the filing PDF)16
22Qulipta tab 60 mg00074709430Listed by the FDA as Quliptaatogepant60 mgtabletAbbVie Inc.12,315 (Schedule G, line 22, page 9 of the filing PDF)25
23Rexulti tab 1 mg59148003713Listed by the FDA as Rexultibrexpiprazole1 mgtabletOtsuka America Pharmaceutical, Inc.12,871 (Schedule G, line 23, page 9 of the filing PDF)16
24Entresto tab 49-51 mg00078077720Listed by the FDA as Entrestosacubitril and valsartan49 mg; 51 mgtablet, film coatedNovartis Pharmaceuticals Corporation13,332 (Schedule G, line 24, page 9 of the filing PDF)25
25Entresto tab 97-103 mg00078069620Listed by the FDA as Entrestosacubitril and valsartan97 mg; 103 mgtablet, film coatedNovartis Pharmaceuticals Corporation13,679 (Schedule G, line 25, page 9 of the filing PDF)23
26Zepbound inj 2.5/0.500002250680Listed by the FDA as Zepboundtirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company16,496 (Schedule G, line 26, page 9 of the filing PDF)20
27Ibsrela tab 50 mg73154005060Listed by the FDA as Ibsrelatenapanor hydrochloride53.2 mgtabletArdelyx, Inc.18,513 (Schedule G, line 27, page 9 of the filing PDF)fewer than 6 (the count is not shown)
28Wegovy inj 1.7 mg00169451714Listed by the FDA as Wegovysemaglutide1.7 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP18,783 (Schedule G, line 28, page 9 of the filing PDF)35
29Wegovy 0.25 mg/0.5 mL inj ( 4 pens)00169452514Listed by the FDA as Wegovysemaglutide0.25 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP17,481 (Schedule G, line 29, page 9 of the filing PDF)fewer than 6 (the count is not shown)
30Wegovy inj 0.5 mg00169450514Listed by the FDA as Wegovysemaglutide0.5 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP20,397 (Schedule G, line 30, page 9 of the filing PDF)37
31Wegovy 1 mg/0.5 mL inj (4 pens)00169450114Listed by the FDA as Wegovysemaglutide1 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP17,481 (Schedule G, line 31, page 9 of the filing PDF)fewer than 6 (the count is not shown)
32Trelegy aer 100 mcg00173088710Listed by the FDA as Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate100 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC21,721 (Schedule G, line 32, page 9 of the filing PDF)80
33Biktarvy tab 50/200/25 mg 3061958250101Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc.22,237 (Schedule G, line 33, page 9 of the filing PDF)8
34Wegovy inj 0.25 mg00169452514Listed by the FDA as Wegovysemaglutide0.25 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP23,900 (Schedule G, line 34, page 9 of the filing PDF)43
35Wegovy inj 1 mg00169450114Listed by the FDA as Wegovysemaglutide1 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP25,336 (Schedule G, line 35, page 9 of the filing PDF)43
36Trelegy aer 200 mcg00173089310Listed by the FDA as Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate200 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC25,634 (Schedule G, line 36, page 9 of the filing PDF)81
37Zenpep cap 40,000 units73562011401Listed by the FDA as Zenpeppancrelipase lipase, pancrelipase protease, pancrelipase amylase40,000 USP units; 126,000 USP units; 168,000 USP unitscapsule, delayed releaseAimmune Therapeutics, Inc.26,258 (Schedule G, line 37, page 9 of the filing PDF)7
38Wegovy pen 2.4 mg/0.75 mL NOV400169452414Listed by the FDA as Wegovysemaglutide2.4 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP26,511 (Schedule G, line 38, page 9 of the filing PDF)47
39Paxlovid tab 300-10000069532130Listed by the FDA as Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc28,138 (Schedule G, line 39, page 9 of the filing PDF)30
40Mounjaro inj 15 mg/0.500002145780Listed by the FDA as Mounjarotirzepatide15 mg/0.5 mLinjection, solutionEli Lilly and Company29,691 (Schedule G, line 40, page 9 of the filing PDF)35
41Wegovy inj 2.4 mg00169452414Listed by the FDA as Wegovysemaglutide2.4 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP30,737 (Schedule G, line 41, page 9 of the filing PDF)56
42Mounjaro inj 10 mg/0.500002147180Listed by the FDA as Mounjarotirzepatide10 mg/0.5 mLinjection, solutionEli Lilly and Company31,145 (Schedule G, line 42, page 9 of the filing PDF)40
43Mounjaro inj 12.5/0.500002146080Listed by the FDA as Mounjarotirzepatide12.5 mg/0.5 mLinjection, solutionEli Lilly and Company31,629 (Schedule G, line 43, page 9 of the filing PDF)38
44Ubrelvy tab 100 mg00023650110Listed by the FDA as Ubrelvyubrogepant100 mgtabletAllergan, Inc.32,545 (Schedule G, line 44, page 9 of the filing PDF)66
45Entresto tab 24-26 mg00078065920Listed by the FDA as Entrestosacubitril and valsartan24 mg; 26 mgtablet, film coatedNovartis Pharmaceuticals Corporation35,331 (Schedule G, line 45, page 9 of the filing PDF)72
46Ozempic 2 mg per dose (8 mg/3 mL) PFP00169477212Listed by the FDA as Ozempicsemaglutide2.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP28,702 (Schedule G, line 46, page 9 of the filing PDF)10
47Ozempic 1 mg per dose (4 mg/3 mL) PFP00169413013Listed by the FDA as Ozempicsemaglutide1.34 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP31,683 (Schedule G, line 47, page 9 of the filing PDF)10
48Ozempic pen 4 mg/3 mL 4Pcsnf00169413013Listed by the FDA as Ozempicsemaglutide1.34 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP15,049 (Schedule G, line 48, page 9 of the filing PDF)59
49Mounjaro inj 2.5/0.500002150680Listed by the FDA as Mounjarotirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company47,459 (Schedule G, line 49, page 9 of the filing PDF)64
50Mounjaro inj 7.5/0.500002148480Listed by the FDA as Mounjarotirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company58,683 (Schedule G, line 50, page 9 of the filing PDF)68
51Ozempic 0.25 or 0.5 mg DOS(2 mg/3 mL)00169418113Listed by the FDA as Ozempicsemaglutide0.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP43,947 (Schedule G, line 51, page 9 of the filing PDF)13
52Ozempic inj 0.25 mg/0.5 mg 3 mL00169418113Listed by the FDA as Ozempicsemaglutide0.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP15,680 (Schedule G, line 52, page 9 of the filing PDF)62
53Nurtec tab 75 mg ODT72618300002Listed by the FDA as Nurtec ODTrimegepant sulfate75 mgtablet, orally disintegratingPfizer Laboratories Div Pfizer Inc61,055 (Schedule G, line 53, page 9 of the filing PDF)145
54Wegovy 1.7 mg/0.75 mL inj ( 4 pens)00169451714Listed by the FDA as Wegovysemaglutide1.7 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP62,133 (Schedule G, line 54, page 9 of the filing PDF)11
55Ozempic inj 2 mg/3 mL00169418113Listed by the FDA as Ozempicsemaglutide0.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP88,254 (Schedule G, line 55, page 9 of the filing PDF)256
56Ozempic inj 4 mg/3 mL00169413013Listed by the FDA as Ozempicsemaglutide1.34 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP88,651 (Schedule G, line 56, page 9 of the filing PDF)249
57Mounjaro inj 5 mg/0.500002149580Listed by the FDA as Mounjarotirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company96,794 (Schedule G, line 57, page 9 of the filing PDF)117
58Ozempic inj 8 mg/3 mL00169477212Listed by the FDA as Ozempicsemaglutide2.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP100,355 (Schedule G, line 58, page 10 of the filing PDF)312
Total Prescription Drugs individually under $5,000234,277 (Schedule G, row for amounts under $5,000, page 10 of the filing PDF)5,031 (Schedule G, claims on the row for amounts under $5,000, page 10 of the filing PDF)
Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement1,677,990 (Schedule G, printed total, page 10 of the filing PDF)7,717 (Schedule G, printed claims total, page 10 of the filing PDF)

What “fewer than 6” means. A count of 1 to 5 is not shown on this site or in its data files. Methods, section 9, says how.

Amounts and counts are the filer’s own, in US dollars. They are written here with commas between thousands, and an amount filed with one decimal place is written with two. No value is changed: the filing and the download keep each figure as typed.

Drug names are the filer’s own words. Filers type them in many ways, so this page writes them one way: capitals, spaces, unit names such as mg and mL, a zero before a decimal point, and commas in long numbers. No word is changed, spelled out or left out, and shorthand stays as the filer typed it. The filing and the download keep each name as typed, and a search here reads both.

“Listed by the FDA as” is not part of the filing. It is the name, ingredient, strength, form and labeler that the U.S. Food and Drug Administration’s National Drug Code Directory lists for the row’s code, as downloaded on 11 November 2026. All 56 rows have one. A row has none when its code is not filed as one 11-digit code or the directory has never listed it. Where the directory has since dropped a code, the name is kept as it was last listed, and the line says so. The directory’s capitals, strengths and unit names are written one way on this page. How a code is matched

Source

Filing PDF
Open Schedule G on the State of Rhode Island's website
SHA-256
66c5d9e7b26b7322aff9bcfdb1bce0caf90d1c880e151e8af01439d0613af4a5
Retrieved
11 November 2026
Pages used
8 to 10 of 12